Jeremy Bahr

Principal, Leavitt Partners, an HMA Company

Articles

Payers Believe Lowering Drug Prices While Improving Patient Access Is Possible—but There’s a Catch

Value-based price for access (VBPA) may increase access of specialty drugs for patients.